Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Effects of two Gβγ-binding proteins – N-terminally truncated phosducin and β-adrenergic receptor kinase C terminus (βARKct) – in heart failure

Gene Therapy volume 10, pages 1354–1361 (2003)Cite this article

Abstract

Myocardial overexpression of the C-terminus of β-adrenergic receptor kinase (βARKct) has been shown to result in a positive inotropic effect or an improvement of survival in heart failure. However, it is not clear whether this beneficial effect is mainly because of dominant-negative inhibition of βARK1, and a consecutive resensitization of β-adrenergic receptors (βAR), or rather due to inhibition of other Gβγ-mediated effects. In this study, we tested whether overexpression of N-terminally truncated phosducin (nt-del-phosducin), another Gβγ-binding protein that does not resensitize βARs owing to simultaneous inhibition of GDP release from Gα subunits, shows the same effects as βARKct. Adenoviral gene transfer was used to express nt-del-phosducin and βARKct in isolated ventricular cardiomyocytes and in myocardium of rabbits, which suffered from heart failure because of rapid ventricular pacing. βAR-stimulated cAMP formation was increased by βARKct, but not by nt-del-phosducin, whereas both proteins inhibited Gβγ-mediated effects. Both transgenes also increased contractility of normal and failing isolated cardiomyocytes and improved contractility in rabbits with heart failure after gene transfer in vivo. In conclusion, overexpression of nt-del-phosducin enhances the contractility of cardiomyocytes to the same extent as βARKct, suggesting that the effects of βARKct might be owing to inhibition of Gβγ rather than to βAR resensitization.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Ungerer M et al. Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in failing human heart. Circulation 1993; 87: 454–463.

    Article  CAS  Google Scholar 

  2. Lohse MJ . Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1993; 1179: 171–188.

    Article  CAS  Google Scholar 

  3. Lefkowitz RJ . G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem 1998; 273: 18677–18680.

    Article  CAS  Google Scholar 

  4. Pitcher JA et al. Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. Science 1992; 257: 1264–1267.

    Article  CAS  Google Scholar 

  5. Akhter SA et al. Restoration of adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci USA 1997; 94: 12100–12105.

    Article  CAS  Google Scholar 

  6. White DC et al. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc Natl Acad Sci USA 2000; 97: 5428–5433.

    Article  CAS  Google Scholar 

  7. Shah AS et al. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction. Circulation 2001; 103: 1311–1316.

    Article  CAS  Google Scholar 

  8. Rockman HA et al. Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci USA 1998; 95: 7000–7005.

    Article  CAS  Google Scholar 

  9. Freeman K et al. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest 2001; 107: 967–974.

    Article  CAS  Google Scholar 

  10. Harding VB et al. Cardiac βARK1 inhibition prolongs survival and augments β-blocker therapy in a mouse model of severe heart failure. Proc Natl Acad Sci USA 2001; 98: 5809–5814.

    Article  CAS  Google Scholar 

  11. Hamm HE . The many faces of G protein signaling. J Biol Chem 1998; 273: 669–672.

    Article  CAS  Google Scholar 

  12. Koch WJ et al. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a βARK inhibitor. Science 1995; 268: 1350–1353.

    Article  CAS  Google Scholar 

  13. Gaudet R, Bohm A, Sigler PB . Crystal structure at 2.4 angstroms resolution of the complex of transducin beta gamma and its regulator, phosducin. Cell 1996; 87: 577–588.

    Article  CAS  Google Scholar 

  14. Bauer PH et al. Phosducin is a protein kinase A-regulated G protein regulator. Nature 1992; 358: 73–76.

    Article  CAS  Google Scholar 

  15. Hekman M, Bauer PH, Söhlemann P, Lohse MJ . Phosducin inhibits receptor phosphorylation by the beta-adrenergic receptor kinase in a PKA-regulated manner. FEBS Lett 1994; 343: 120–124.

    Article  CAS  Google Scholar 

  16. Müller S et al. Interactions of phosducin with defined Gβγ subunits. J Biol Chem 1996; 271: 11781–11786.

    Article  Google Scholar 

  17. Blüml K et al. A small region in phosducin inhibits G-protein βy subunit function. J Biol Chem 1997; 16: 4908–4915.

    Google Scholar 

  18. Schulz K et al. Expression of phosducin in a phosducin-negative cell line reveals functions of a Gβγ-binding protein. J Biol Chem 1996; 271: 22546–22551.

    Article  CAS  Google Scholar 

  19. Laugwitz KL et al. Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum Gene Ther 2001; 12: 2051–2063.

    Article  CAS  Google Scholar 

  20. Korzick DH et al. Transgenic manipulation of beta-adrenergic receptor kinase modifies cardiac myocyte contraction to norepinephrine. Am J Physiol 1997; 272: H590–H596.

    CAS  PubMed  Google Scholar 

  21. Clapham DE, Neer EJ . New roles for G-protein beta gamma-dimers in transmembrane signalling. Nature 1993; 365: 403–436.

    Article  CAS  Google Scholar 

  22. Luttrell LM et al. β-arrestin-dependent formation of β2-adrenergic receptor – src protein kinase complexes. Science 1999; 283: 655–661.

    Article  CAS  Google Scholar 

  23. Naga-Prasad SV et al. G protein-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem 2000; 275: 4693–4698.

    Article  CAS  Google Scholar 

  24. Yoshida T et al. The phosphorylation state of phosducin determines its ability to block transducin subunit interactions and inhibit transducin binding to activated rhodopsin. J Biol Chem 1994; 269: 24050–24057.

    CAS  PubMed  Google Scholar 

  25. Thulin CD et al. Modulation of the G protein regulator phosducin by Ca2+/calmodulin-dependent protein kinase II phosphorylation and 14-3-3 protein binding. J Biol Chem 2001; 276: 23805–23815.

    Article  CAS  Google Scholar 

  26. He TC et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509–2514.

    Article  CAS  Google Scholar 

  27. Weig HJ et al. Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors in vivo by ultrasound-guided injection or trans-coronary delivery. Circulation 2000; 101: 1578–1585.

    Article  CAS  Google Scholar 

  28. Laugwitz KL et al. Gene transfer of heterologous G protein-coupled receptors to cardiomyocytes: differential effects on contractility. Circ Res 2001; 88: 688–695.

    Article  CAS  Google Scholar 

  29. Bradford MM . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248–254.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Z Li and K-L Laugwitz: Both authors contributed equally to this work

Authors and Affiliations

  1. ProCorde, Martinsried, Germany

    Z Li, C Baumgartner, K Rosport, G Münch & M Ungerer

  2. 1. Medizinische Klinik and Deutsches Herzzentrum München, Technische Universität, Munich, Germany

    K-L Laugwitz, K Pinkernell, I Pragst, E Hoffmann & A Moretti

  3. Institut für Pharmakologie, Universität Würzburg, Germany

    J Humrich & M J Lohse

Authors
  1. Z Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K-L Laugwitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Pinkernell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I Pragst
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Baumgartner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K Rosport
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G Münch
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Moretti
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J Humrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M J Lohse
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. M Ungerer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Z., Laugwitz, KL., Pinkernell, K. et al. Effects of two Gβγ-binding proteins – N-terminally truncated phosducin and β-adrenergic receptor kinase C terminus (βARKct) – in heart failure. Gene Ther 10, 1354–1361 (2003). https://doi.org/10.1038/sj.gt.3301995

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301995

This article is cited by

Search

Advanced search

Quick links